Medicines and Healthcare products Regulatory Agency: Redundancy

(asked on 14th September 2021) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what discussions he has had with executive officers at the Medicines and Healthcare products Regulatory Agency regarding the proposed redundancies at that agency.


Answered by
Edward Argar Portrait
Edward Argar
Minister of State (Ministry of Justice)
This question was answered on 1st October 2021

Ministers and officials meet regularly with the Medicines and Healthcare products Regulatory Agency (MHRA) to discuss a range of issues, including its transformation plans to become a more dynamic and efficient organisation. The Department has not made a specific assessment of the MHRA’s staffing levels.

The MHRA is carrying out a series of equality and diversity impact assessments throughout the transformation continues to engage with trade unions and employees through a formal consultation as well as continuing opportunities for engagement with senior leaders.

Reticulating Splines